These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10785891)

  • 1. Persistent central diabetes insipidus presenting in a very low birth weight infant successfully managed with intranasal dDAVP.
    Stapleton G; DiGeronimo RJ
    J Perinatol; 2000 Mar; 20(2):132-4. PubMed ID: 10785891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of central diabetes insipidus with oral desmopressin in a premature neonate.
    Atasay B; Berberoğlu M; Günlemez A; Evliyaoğlu O; Adiyaman P; Unal S; Arsan S; Ocal G
    J Pediatr Endocrinol Metab; 2004 Feb; 17(2):227-30. PubMed ID: 15055359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient diabetes insipidus in a preterm neonate and the challenge of desmopressin dosing.
    Van der Kaay DC; Van Heel WJ; Dudink J; van den Akker EL
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):769-71. PubMed ID: 24670345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Central diabetes insipidus in the very young child. Treatment with oral desmopressin].
    Fjellestad-Paulsen A; Crosnier H; Czernichow P
    Arch Fr Pediatr; 1988 Dec; 45(10):787-90. PubMed ID: 3071285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of DDAVP (1-desamino-8-D-arginine vasopressin) in children with central diabetes insipidus (author's transl)].
    Tomita M; Nakagawa S; Saito N; Sakurada N; Nonoda A
    Horumon To Rinsho; 1979 Jun; 27(6):681-5. PubMed ID: 466837
    [No Abstract]   [Full Text] [Related]  

  • 6. Idiopathic central diabetes insipidus presenting in a very low birth weight infant successfully managed with lyophilized sublingual desmopressin.
    Hanta D; Törer B; Temiz F; Kılıçdağ H; Gökçe M; Erdoğan Ö
    Turk J Pediatr; 2015; 57(1):90-3. PubMed ID: 26613228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of neonatal diabetes insipidus with desmopressin.
    Giacoia GP; Watson S; Karathanos A
    South Med J; 1984 Jan; 77(1):75-7. PubMed ID: 6695224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDAVP in the treatment of central diabetes insipidus.
    Robinson AG
    N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus.
    Mavinkurve M; McGrath N; Johnston N; Moloney S; Murphy NP; Hawkes CP
    J Pediatr Endocrinol Metab; 2017 May; 30(6):623-628. PubMed ID: 28599389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient gestational diabetes insipidus: report of two cases and review of pathophysiology and treatment.
    El-Hennawy AS; Bassi T; Koradia N; Bocirnea A
    J Matern Fetal Neonatal Med; 2003 Nov; 14(5):349-52. PubMed ID: 14986811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient diabetes insipidus in a very-low-birthweight preterm infant with intraventricular haemorrhage.
    Molnar Z; Sotiridou E; Dixon H; Ogilvy-Stuart A
    Acta Paediatr; 2012 Sep; 101(9):e389-90. PubMed ID: 22731519
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of diabetes insipidus with Minirin. Switch from nasal to oral administration].
    Czernichow P
    Ann Endocrinol (Paris); 1998 Dec; 59(5):407-9. PubMed ID: 9949892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pregnancy in diabetes insipidus--a case report with review of the literature].
    Cap R; Lüscher KP
    Zentralbl Gynakol; 1990; 112(12):773-8. PubMed ID: 2220171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
    Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
    Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
    Tanae A; Shimizu K; Yoshida S
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
    Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
    Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetes insipidus--with special reference to DDAVP therapy].
    Shimizu K
    Nihon Rinsho; 1979; 37(4):849-55. PubMed ID: 449070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.